Targeted therapy for medullary and extramedullary relapse of FLT3-ITD acute myeloid leukemia following allogeneic hematopoietic stem cell transplantation

Targeted therapy for medullary and extramedullary relapse of FLT3-ITD acute myeloid leukemia following allogeneic hematopoietic stem cell transplantation

We report a case with extramedullary tumors affecting the supraclavicular region that presented as a relapse of acute myeloid leukemia (AML) with FLT3-ITD mutation after allogeneic hematopoietic stem cell transplantation (allo-HSCT). Treatment with gilteritinib resulted in remarkable response with d...

Full description

Bibliographic Details
Main Authors: Takahiro Kumode, Shinya Rai, Hirokazu Tanaka, J. Luis Espinoza, Hiroaki Kakutani, Yosaku Watatani, Shuji Minamoto, Yasuhiro Taniguchi, Shoko Nakayama, Yasuyoshi Morita, Takashi Ashida, Itaru Matsumura
Format: Article
Language:English
Published: Elsevier 2020-01-01
Series:Leukemia Research Reports
Subjects:
Myeloid sarcoma
Acute myeloid leukemia
FLT3-ITD
Gilteritinib
Online Access:http://www.sciencedirect.com/science/article/pii/S221304892030025X

Internet

http://www.sciencedirect.com/science/article/pii/S221304892030025X

Similar Items